1 Zuckerberg San Francisco General Hospital and Trauma Center, Division of Hematology-Oncology, Department of Medicine, University of California at San Francisco, San Francisco.
2 Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.
3 Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS) at Complutense University of Madrid, Madrid, Spain.